Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NIH conference. Membranous nephropathy.

H A Austin1, T T Antonovych, K MacKay

  • 1National Institutes of Health, Bethesda, MD 20892.

Annals of Internal Medicine
|April 15, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Royal College of Radiologists Guidance Statements on the Use of Auto-contouring in Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Atmospheric Pressure Plasma Functionalization of Sealed PDMS Microfluidics: Application to Capillary Pumping and Enhanced Cell Growth.

ChemPlusChem·2024
Same author

Regional European genetic ancestry predicts type I interferon level and risk of severe viral infection.

QJM : monthly journal of the Association of Physicians·2024
Same author

Spinal cord injury as a result of Staphylococcus aureus pyogenic spinal infection complicating infected atopic eczema: two case reports.

Spinal cord series and cases·2023
Same author

A Review of the Metrics Used to Assess Auto-Contouring Systems in Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Artificial Intelligence for Radiotherapy Auto-Contouring: Current Use, Perceptions of and Barriers to Implementation.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Membranous nephropathy, a cause of nephrotic syndrome, involves immune injury and risks kidney failure. Research explores immunosuppressants and lipid-lowering drugs to manage this kidney disease.

Area of Science:

  • Nephrology
  • Immunology
  • Internal Medicine

Background:

  • Membranous nephropathy is a leading cause of adult nephrotic syndrome globally.
  • It involves immune-mediated glomerular injury, leading to potential end-stage renal failure and hyperlipidemia complications.
  • Pathogenesis includes subepithelial immune complex deposition and complement activation.

Purpose of the Study:

  • To review the current understanding of membranous nephropathy's pathophysiology.
  • To discuss treatment strategies, including immunosuppressants and supportive therapies.
  • To highlight ongoing research and clinical trials for optimizing treatment efficacy and safety.

Main Methods:

  • Literature review of membranous nephropathy pathogenesis and treatment.

Related Experiment Videos

  • Analysis of current clinical trial data on immunosuppressive agents.
  • Evaluation of evidence for lipid-lowering therapy in persistent nephrotic syndrome.

    • Main Results:

    • Immune complex deposition and complement activation are key features.
    • Efficacy of alternate-day corticosteroids is not well-established.
    • Ongoing trials compare cytotoxic drugs or cyclosporine A with prednisone.

    Conclusions:

    • Effective management requires addressing underlying causes and immune mechanisms.
    • Immunosuppressive therapy aims to balance efficacy and toxicity.
    • Lipid-lowering therapy is crucial for managing hyperlipidemia and cardiovascular risks.